Cargando…
The Targeting of Nuclear Factor Kappa B by Drugs Adopted for the Prevention and Treatment of Preeclampsia
Preeclampsia (PE) is characterised by high levels and activity of the transcription factor Nuclear Factor kappa B (NFĸB) in the maternal blood and placental cells. This factor is responsible for the regulation of over 400 genes known to influence processes related to inflammation, apoptosis and angi...
Autor principal: | Sakowicz, Agata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911173/ https://www.ncbi.nlm.nih.gov/pubmed/35270023 http://dx.doi.org/10.3390/ijms23052881 |
Ejemplares similares
-
New Ideas for the Prevention and Treatment of Preeclampsia and Their Molecular Inspirations
por: Sakowicz, Agata, et al.
Publicado: (2023) -
Canonical, Non-Canonical and Atypical Pathways of Nuclear Factor кb Activation in Preeclampsia
por: Sakowicz, Agata, et al.
Publicado: (2020) -
Reliability of Rodent and Rabbit Models in Preeclampsia Research
por: Sakowicz, Agata, et al.
Publicado: (2022) -
Nuclear Factor-kappa B as a Resistance Factor to Platinum-Based Antineoplasic Drugs
por: Lagunas, Vilma Maldonado, et al.
Publicado: (2008) -
Nuclear factor kappaB (NF-kappaB) pathway as a therapeutic target in rheumatoid arthritis.
por: Jue, D. M., et al.
Publicado: (1999)